Christian Rolfo

Citado por

	Total	Desde 2019
Citas	24462	15515
Índice h	65	57
Índice i10	251	228

3300

1650

825

2475

201020112012201320142015201620172018201920202021202220232024216 316 456 744 904 1210 1413 1592 1731 2098 2614 3227 3241 3204 1054

Acceso público

Ver todo

66 artículos

16 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Alessandro RussoMedical Oncology Unit AO Papardo & Department of Human Pathology, University of MessinaDirección de correo verificada de studenti.unime.it
Antonio RussoUniversity of PalermoDirección de correo verificada de community.unipa.it
Oscar ArrietaHead of the Thoracic Oncology Unit, Instituto Nacional de Cancerología de MexicoDirección de correo verificada de unam.mx
Umberto MalapelleDepartment of Public Health, University Federico II of NaplesDirección de correo verificada de unina.it
Elisa GiovannettiAssociate Professor - UHD - Amsterdam UMC (VUmc) & FPS, PisaDirección de correo verificada de vumc.nl
Filip LardonFull professor - Vice-rector, University of AntwerpDirección de correo verificada de uantwerpen.be
Viviana BazanUniversity of PalermoDirección de correo verificada de usa.net
Jan P van MeerbeeckUniversiteit Antwerpen - Universitair Ziekenhuis Antwerpen- Universiteit GentDirección de correo verificada de uza.be
Julie JacobsUniversiteit AntwerpenDirección de correo verificada de uantwerpen.be
Salvatore SienaUniversità degli Studi di Milano, Dipartimento di Oncologia, Ospedale Niguarda, Milano, ItalyDirección de correo verificada de unimi.it
GJ PetersProfessor of Pharmacology of Cytostatics, Amsterdam UMC, location VUMC, Amsterdam; and MedicalDirección de correo verificada de amsterdamumc.nl
Christophe DebenPhDDirección de correo verificada de uantwerpen.be
Pasquale PisapiaUniversity of Naples Federico IIDirección de correo verificada de unina.it
Laure SorberPhD, Oncology, Antwerp UniversityDirección de correo verificada de uantwerpen.be
Luis CorralesCIMCA / HSJD-CCSS Costa RicaDirección de correo verificada de cimcacr.com
Luis Leonardo Rojas PuentesCentro de tratamiento e investigación sobre cáncer (CTIC)Luis Carlos Sarmiento ÁnguloDirección de correo verificada de fctic.org
Rafael SireraProfessor of Cell BiologyDirección de correo verificada de btc.upv.es
Joseph A. PintoOncosalud-AUNADirección de correo verificada de gecoperu.org
Carlos CampsProfessor MedicineDirección de correo verificada de gva.es
daniele santiniprofessor in general pathologyDirección de correo verificada de unicampus.it

Seguir

Christian Rolfo

Professor in Oncology, Head of Phase I -Early Clinical Trials Unit, Oncology, Antwerp University

Dirección de correo verificada de uza.be

thoracic oncology liquid biopsies exosomes drug development clincial trials


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre … R Rosell, E Carcereny, R Gervais, A Vergnenegre, B Massuti, E Felip, ... The lancet oncology 13 (3), 239-246, 2012	6260	2012
Screening for epidermal growth factor receptor mutations in lung cancer R Rosell, T Moran, C Queralt, R Porta, F Cardenal, C Camps, M Majem, ... New England Journal of Medicine 361 (10), 958-967, 2009	2946	2009
Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ... Journal of thoracic oncology 13 (9), 1248-1268, 2018	626	2018
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study U Banerji, CML van Herpen, C Saura, F Thistlethwaite, S Lord, V Moreno, ... The Lancet Oncology 20 (8), 1124-1135, 2019	416	2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials A Drilon, S Siena, R Dziadziuszko, F Barlesi, MG Krebs, AT Shaw, ... The Lancet Oncology 21 (2), 261-270, 2020	410	2020
Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer C Rolfo, P Mack, GV Scagliotti, C Aggarwal, ME Arcila, F Barlesi, T Bivona, ... Journal of Thoracic Oncology 16 (10), 1647-1662, 2021	342	2021
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target M Román, I Baraibar, I López, E Nadal, C Rolfo, S Vicent, I Gil-Bazo Molecular cancer 17, 1-14, 2018	334	2018
Impact of the COVID-19 pandemic on cancer care: a global collaborative study AR Jazieh, H Akbulut, G Curigliano, A Rogado, AA Alsharm, ED Razis, ... JCO global oncology 6, 1428-1438, 2020	255	2020
The role of nuclear factor-kappa B signaling in human cervical cancer S Tilborghs, J Corthouts, Y Verhoeven, D Arias, C Rolfo, XB Trinh, ... Critical reviews in oncology/hematology 120, 141-150, 2017	252	2017
FGFR a promising druggable target in cancer: Molecular biology and new drugs R Porta, R Borea, A Coelho, S Khan, A Araújo, P Reclusa, T Franchina, ... Critical reviews in oncology/hematology 113, 256-267, 2017	242	2017
A comparison of cell-free DNA isolation kits: isolation and quantification of cell-free DNA in plasma L Sorber, K Zwaenepoel, V Deschoolmeester, G Roeyen, F Lardon, ... The journal of molecular diagnostics 19 (1), 162-168, 2017	230	2017
Liquid biopsies in lung cancer: the new ambrosia of researchers C Rolfo, M Castiglia, D Hong, R Alessandro, I Mertens, G Baggerman, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 539-546, 2014	221	2014
Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies N Boeckx, R Koukakis, KO De Beeck, C Rolfo, G Van Camp, S Siena, ... Annals of Oncology 28 (8), 1862-1868, 2017	216	2017
RET fusions in solid tumors AY Li, MG McCusker, A Russo, KA Scilla, A Gittens, K Arensmeyer, ... Cancer treatment reviews 81, 101911, 2019	187	2019
CD70: An emerging target in cancer immunotherapy J Jacobs, V Deschoolmeester, K Zwaenepoel, C Rolfo, K Silence, ... Pharmacology & therapeutics 155, 1-10, 2015	187	2015
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ... Expert review of molecular diagnostics 17 (3), 209-215, 2017	177	2017
Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients L Sorber, K Zwaenepoel, V Deschoolmeester, PEY Van Schil, ... Lung cancer 107, 100-107, 2017	175	2017
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer A Leonetti, B Wever, G Mazzaschi, YG Assaraf, C Rolfo, F Quaini, M Tiseo, ... Drug Resistance Updates 46, 100644, 2019	169	2019
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis F Passiglia, G Bronte, V Bazan, C Natoli, S Rizzo, A Galvano, A Listì, ... Oncotarget 7 (15), 19738, 2016	169	2016
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges VSS Bradley CA, Salto-Tellez M, Laurent-Puig P, Bardelli A, Rolfo C ... Nat Rev Clin Oncol, 2017	165	2017

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores